Northern Trust Company of Connecticut’s Genomic Health, Inc. GHDX Stock Holding History

Northern Trust Company of Connecticut’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$266K	Hold	9,079	–	–	﹤0.01%	1708
2013 Q3	$278K	Hold	9,079	–	–	﹤0.01%	1660
2013 Q2	$288K	Buy	+9,079	New	+$298K	﹤0.01%	1609

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's GHDX Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Genomic Health, Inc. (GHDX) position steady in Q4 2013 at 9,079 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Northern Trust Company of Connecticut first reported a position in GHDX in Q2 2013 and has held it in 3 quarters since. The position peaked at $288K in Q2 2013. 120 funds tracked by Wall St. Rank hold GHDX as of Q4 2013.

Northern Trust Company of Connecticut held 9,079 shares of Genomic Health, Inc. worth $266K as of Q4 2013.
Northern Trust Company of Connecticut left its Genomic Health, Inc. share count unchanged in Q4 2013.
Genomic Health, Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1708 holding.
Northern Trust Company of Connecticut first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Genomic Health, Inc. position peaked at $288K in Q2 2013.
120 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.